This is a 12-week open-label extension study for participants completing study NCT06221852.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in brain redox nicotinamide adenine dinucleotide metabolites ratio (NAD+/NADH)
Timeframe: 24 weeks
Change in brain creatine kinase forward reaction rate (kf)
Timeframe: 24 weeks
Change in insulin resistance
Timeframe: 24 weeks
Change in psychotic symptoms
Timeframe: 24 weeks
Change in depressive symptoms
Timeframe: 24 weeks
Change in mania symptoms
Timeframe: 24 weeks
Change in Clinical Global Impression (CGI) Scale
Timeframe: 24 weeks